Emergent BioSolutions
The Latest
-
FDA Inspectors Find A Big Mess At U.S. Plant Under Contract To Make J&J Vaccine
Among the troubling observations were unsealed bags of medical waste and peeling paint, the FDA said. 
Among the troubling observations were unsealed bags of medical waste and peeling paint, the FDA said. -
AstraZeneca, Emergent Bio Sign $87-M Deal To Produce COVID-19 Drug In US
AstraZeneca also considering mega-merger with Gilead Sciences to build a $240 billion empire. 
AstraZeneca also considering mega-merger with Gilead Sciences to build a $240 billion empire.
